scholarly journals Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells

2015 ◽  
Vol 2015 ◽  
pp. 1-17 ◽  
Author(s):  
Simona Ronchetti ◽  
Erika Ricci ◽  
Maria Grazia Petrillo ◽  
Luigi Cari ◽  
Graziella Migliorati ◽  
...  

Glucocorticoid-induced tumour necrosis factor receptor-related protein (GITR, TNFRSF18, and CD357) is expressed at high levels in activated T cells and regulatory T cells (Tregs). In this review, we present data from mouse and human studies suggesting that GITR is a crucial player in the differentiation of thymic Tregs (tTregs), and expansion of both tTregs and peripheral Tregs (pTregs). The role of GITR in Treg expansion is confirmed by the association of GITR expression with markers of memory T cells. In this context, it is not surprising that GITR appears to be a marker of active Tregs, as suggested by the association of GITR expression with other markers of Treg activation or cytokines with suppressive activity (e.g., IL-10 and TGF-β), the presence of GITR+cells in tissues where Tregs are active (e.g., solid tumours), or functional studies on Tregs. Furthermore, some Treg subsets including Tr1 cells express either low or no classical Treg markers (e.g., FoxP3 and CD25) and do express GITR. Therefore, when evaluating changes in the number of Tregs in human diseases, GITR expression must be evaluated. Moreover, GITR should be considered as a marker for isolating Tregs.

2016 ◽  
Vol 185 (2) ◽  
pp. 263-270 ◽  
Author(s):  
A. Verwoerd ◽  
D. Hijdra ◽  
A. D. M. Vorselaars ◽  
H. A. Crommelin ◽  
C. H. M. van Moorsel ◽  
...  

Immunology ◽  
2014 ◽  
Vol 142 (2) ◽  
pp. 193-201 ◽  
Author(s):  
Ya Hu ◽  
Haitao Xiao ◽  
Tingchen Shi ◽  
Joost J. Oppenheim ◽  
Xin Chen

2012 ◽  
Vol 2012 ◽  
pp. 1-16 ◽  
Author(s):  
Ricardo F. Antunes ◽  
Juan Carlos Kaski ◽  
Ingrid E. Dumitriu

Atherosclerosis is a chronic inflammatory disease that is mediated by both the innate and adaptive immune responses. T lymphocytes, that together with B cells are the cellular effectors of the adaptive immune system, are currently endowed with crucial roles in the development and progression of atherosclerosis. Costimulatory receptors are a class of molecules expressed by T lymphocytes that regulate the activation of T cells and the generation of effector T-cell responses. In this review we present the roles of costimulatory receptors of the tumour necrosis factor receptor (TNFR) superfamily in atherosclerosis and discuss the implications for future therapies that could be used to specifically modulate the immune response of pathogenic T cells in this disease.


Sign in / Sign up

Export Citation Format

Share Document